USFDA issues EIR for Suven Pharma arm Casper Parma Ruchika Sharma4 Oct 2022 4:27 PM ISTThe inspection concluded with no observation (FDA-483) issued.
Casper Pharma Hyderabad facility concludes USFDA inspection with zero observations Ruchika Sharma31 July 2022 1:00 PM ISTHyderabad: Suven Pharmaceuticals Ltd has announced that the US Food and Drug Administration (USFDA) has completed a pre-approval inspection at Casper...
Suven Pharma, CSIR-IICT, NIIST collaborate for COVID drug Molnupiravir Ruchika Sharma11 Jun 2021 11:00 AM ISTAccording to a study published in the journal "Nature Microbiology," the drug can completely suppress the COVID virus transmission within 24 hours,...
Suven Pharma posts net profit of Rs 74.18 crore in Q4 Ruchika Sharma21 Jun 2020 9:30 AM ISTNew Delhi: Drug firm Suven Pharmaceuticals on Thursday reported a consolidated net profit of Rs 74.18 crore for the quarter ended March 31, 2020.The...
